Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

Brain Oxygenation-II

ClinicalTrials.gov ID: NCT05171881

Public ClinicalTrials.gov record NCT05171881. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Brain Oxygenation in Extremely Preterm Infants-II

Study identification

NCT ID
NCT05171881
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Valerie Chock, M.D., M.S. Epi
Other
Enrollment
100 participants

Conditions and interventions

Interventions

  • Intervention for cerebral hypoxia Other

Other

Eligibility (public fields only)

Age range
Up to 6 Hours
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 6, 2022
Primary completion
Nov 30, 2024
Completion
Mar 31, 2025
Last update posted
Apr 17, 2024

2022 – 2025

United States locations

U.S. sites
5
U.S. states
4
U.S. cities
5
Facility City State ZIP Site status
Loma Linda University Loma Linda California 92350
Stanford University Palo Alto California 94304
Washington University in Saint Louis St Louis Missouri 63110
University of Texas- Southwestern Medical Center Dallas Texas 75390
University of Virginia Charlottesville Virginia 22903

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05171881, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05171881 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →